Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Nov 30, 2012
Stent system study to support FDA and Japanese regulatory approvals for the treatment of atherosclerotic coronary lesions; received CE approval last month.
-
Nov 20, 2012Devices Projected to Have up to Twice the Longevity of Comparable Products
Devices projected to have up to twice the longevity of comparable products.
-
Nov 8, 2012
Company to consolidate Natick, Mass. headquarters into existing Marlborough site to create collaborative campus setting; to be completed by summer 2014.
-
Nov 6, 2012
MADIT-RIT clinical trial study results published today in the New England Journal of Medicine
-
Nov 1, 2012
Appointment completes company's CEO transition plan; Mahoney Replaces Interim CEO William H. (Hank) Kucheman.
-
Oct 31, 2012
Innovative bioabsorbable coating is the first to complete absorption shortly after drug elution ends at three months.
-
Oct 24, 2012
Language update supports the strong safety profile for PROMUS Element and PROMUS Element Plus Stents.
-
Oct 23, 2012
PLATINUM Long Lesion clinical results presented at TCT 2012 show no heart attack or stent thrombosis at two-year follow-up.
-
Oct 23, 2012
Twelve-month data presented at TCT 2012 support safety and efficacy of Epic stent in iliac stenting.
-
Oct 23, 2012
Results presented on cost effectiveness and clinical benefits for older patients of the WATCHMAN® Left Atrial Appendage Closure Device; Lotus™ Aortic Valve System feasibility trial results reviewed.